Benefits of oveporexton in narcolepsy type 1
Author:
- 9 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 21 (7) , 348
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1New England Journal of Medicine, 2025
- Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatmentNature Reviews Neurology, 2019